These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

286 related articles for article (PubMed ID: 33955121)

  • 1. Recurrence Outcomes Less Favorable in T1 Rectal Cancer than in T1 Colon Cancer.
    Chang LC; Shun CT; Lin BR; Sanduleanu S; Hsu WF; Wu MS; Chiu HM
    Oncologist; 2021 Sep; 26(9):e1548-e1554. PubMed ID: 33955121
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Risk factors of recurrence in T1 colorectal cancers treated by endoscopic resection alone or surgical resection with lymph node dissection.
    Kouyama Y; Kudo SE; Miyachi H; Ichimasa K; Matsudaira S; Misawa M; Mori Y; Kudo T; Hayashi T; Wakamura K; Ishida F; Hamatani S
    Int J Colorectal Dis; 2018 Aug; 33(8):1029-1038. PubMed ID: 29748707
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Liver metastases from colon and rectal cancer in terms of differences in their clinical parameters].
    Liška V; Emingr M; Skála M; Pálek R; Troup O; Novák P; Vyčítal O; Skalický T; Třeška V
    Rozhl Chir; 2016 Feb; 95(2):69-77. PubMed ID: 27008168
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effect of Comorbidities in Stage II/III Colorectal Cancer Patients Treated With Surgery and Neoadjuvant/Adjuvant Chemotherapy: A Single-Center, Observational Study.
    Baretti M; Rimassa L; Personeni N; Giordano L; Tronconi MC; Pressiani T; Bozzarelli S; Santoro A
    Clin Colorectal Cancer; 2018 Sep; 17(3):e489-e498. PubMed ID: 29650416
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prognostic impact of primary tumor location in Stage III colorectal cancer-right-sided colon versus left-sided colon versus rectum: a nationwide multicenter retrospective study.
    Shida D; Inoue M; Tanabe T; Moritani K; Tsukamoto S; Yamauchi S; Sugihara K; Kanemitsu Y
    J Gastroenterol; 2020 Oct; 55(10):958-968. PubMed ID: 32651860
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Characteristics of recurrence after curative resection for T1 colorectal cancer: Japanese multicenter study.
    Kobayashi H; Mochizuki H; Morita T; Kotake K; Teramoto T; Kameoka S; Saito Y; Takahashi K; Hase K; Oya M; Maeda K; Hirai T; Kameyama M; Shirouzu K; Sugihara K
    J Gastroenterol; 2011 Feb; 46(2):203-11. PubMed ID: 21152938
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Risk of lymph node metastasis in T1 carcinoma of the colon and rectum.
    Nascimbeni R; Burgart LJ; Nivatvongs S; Larson DR
    Dis Colon Rectum; 2002 Feb; 45(2):200-6. PubMed ID: 11852333
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Long-term outcomes after resection of para-aortic lymph node metastasis from left-sided colon and rectal cancer.
    Nakai N; Yamaguchi T; Kinugasa Y; Shiomi A; Kagawa H; Yamakawa Y; Numata M; Furutani A
    Int J Colorectal Dis; 2017 Jul; 32(7):999-1007. PubMed ID: 28382511
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prognostic impact of residual lateral lymph node metastasis after neoadjuvant (chemo)radiotherapy in patients with advanced low rectal cancer.
    Akiyoshi T; Toda S; Tominaga T; Oba K; Tomizawa K; Hanaoka Y; Nagasaki T; Konishi T; Matoba S; Fukunaga Y; Ueno M; Kuroyanagi H
    BJS Open; 2019 Dec; 3(6):822-829. PubMed ID: 31832589
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prognostic value of metastatic lymph node regression grade after neoadjuvant chemoradiotherapy in patients with locally advanced rectal cancer.
    Tominaga T; Akiyoshi T; Yamamoto N; Oba K; Nagasaki T; Yamaguchi T; Konishi T; Fukunaga Y; Ueno M
    Surgery; 2019 Dec; 166(6):1061-1067. PubMed ID: 31345564
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Lymphovascular invasion: a comprehensive appraisal in colon and rectal adenocarcinoma.
    Hogan J; Chang KH; Duff G; Samaha G; Kelly N; Burton M; Burton E; Coffey JC
    Dis Colon Rectum; 2015 Jun; 58(6):547-55. PubMed ID: 25944426
    [TBL] [Abstract][Full Text] [Related]  

  • 12. T1 adenocarcinoma of the rectum: transanal excision or radical surgery?
    Bentrem DJ; Okabe S; Wong WD; Guillem JG; Weiser MR; Temple LK; Ben-Porat LS; Minsky BD; Cohen AM; Paty PB
    Ann Surg; 2005 Oct; 242(4):472-7; discussion 477-9. PubMed ID: 16192807
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Survival outcome of local excision versus radical resection of colon or rectal carcinoma: a Surveillance, Epidemiology, and End Results (SEER) population-based study.
    Bhangu A; Brown G; Nicholls RJ; Wong J; Darzi A; Tekkis P
    Ann Surg; 2013 Oct; 258(4):563-9; discussion 569-71. PubMed ID: 23979270
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Lymph node metastasis in T1 adenocarcinoma of the colon and rectum.
    Okabe S; Shia J; Nash G; Wong WD; Guillem JG; Weiser MR; Temple L; Sugihara K; Paty PB
    J Gastrointest Surg; 2004 Dec; 8(8):1032-9; discussion 1039-40. PubMed ID: 15585391
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Outcome of right- and left-sided colonic and rectal cancer following surgical resection.
    Suttie SA; Shaikh I; Mullen R; Amin AI; Daniel T; Yalamarthi S
    Colorectal Dis; 2011 Aug; 13(8):884-9. PubMed ID: 20594201
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Rectum-preserving surgery after consolidation neoadjuvant therapy or totally neoadjuvant therapy for low rectal cancer: a preliminary report].
    Huang Y; Huang SH; Chi P; Wang XJ; Lin HM; Lu XR; Ye DX; Lin Y; Deng Y
    Zhonghua Wei Chang Wai Ke Za Zhi; 2020 Mar; 23(3):281-288. PubMed ID: 32192308
    [No Abstract]   [Full Text] [Related]  

  • 17. Descriptive characteristics of colon and rectal cancer recurrence in a Danish population-based study.
    Holmes AC; Riis AH; Erichsen R; Fedirko V; Ostenfeld EB; Vyberg M; Thorlacius-Ussing O; Lash TL
    Acta Oncol; 2017 Aug; 56(8):1111-1119. PubMed ID: 28339306
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Risk of recurrence in high-risk T1 colon cancer following endoscopic and surgical resection: registry-based cohort study.
    Nilsson E; Wetterholm E; Syk I; Thorlacius H; Rönnow CF
    BJS Open; 2024 May; 8(3):. PubMed ID: 38869239
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Validation of the 12-gene colon cancer recurrence score as a predictor of recurrence risk in stage II and III rectal cancer patients.
    Reimers MS; Kuppen PJ; Lee M; Lopatin M; Tezcan H; Putter H; Clark-Langone K; Liefers GJ; Shak S; van de Velde CJ
    J Natl Cancer Inst; 2014 Nov; 106(11):. PubMed ID: 25261968
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Recurrence risk and prognostic parameters in stage I rectal cancers.
    Cihan S; Kucukoner M; Ozdemir N; Dane F; Sendur MA; Yazilitas D; Urakci Z; Durnali A; Yuksel S; Aksoy S; Colak D; Seker MM; Taskoylu BY; Oguz A; Isikdogan A; Zengin N
    Asian Pac J Cancer Prev; 2014; 15(13):5337-41. PubMed ID: 25040998
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.